Suppression of myoclonus in SCA2 by piracetam

Authors


Abstract

We report on a 30-year-old patient with advanced cerebellar degeneration due to SCA2. He presented with severe myoclonus, which was resistant to conventional therapy and dramatically improved after administration of 12–18 gm/die piracetam. Piracetam may be considered in the treatment of refractory myoclonus in spinocerebellar degenerations. © 2005 Movement Disorder Society

Ancillary